BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND TOP1, RP3-511B24_2, 7150, ENSG00000198900, TOPI, P11387
60790 results:

  • 1. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
    Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
    World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence.
    Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
    Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
    Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
    Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Treatment of Osteoporosis in Men on Androgen Deprivation Therapy in Japan.
    Nishimoto H; Inui A; Mifune Y; Yamaura K; Bando Y; Okamura Y; Hara T; Terakawa T; Kuroda R
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674197
    [No Abstract]    [Full Text] [Related]  

  • 5. A Community-Based prostate cancer Screening and Education Program for Asian American Men in Medically Underserved Communities.
    Cho D; Gor B; Hwang H; Wang X; Hernandez M; Jones LA; Frost J; Roberson P; Pettaway CA
    Int J Environ Res Public Health; 2024 Mar; 21(4):. PubMed ID: 38673327
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrated aerobic exercise with LDE-docetaxel treatment: a novel approach to combat prostate cancer progression.
    Veras ASC; Batista VRG; Correia RR; de Almeida Tavares ME; Rubira RJG; Tavares ER; Giometti IC; Maranhão RC; Teixeira GR
    Sci Rep; 2024 Apr; 14(1):9626. PubMed ID: 38671015
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Breakthrough electroneutron multi-response miniature dosimetry/spectrometry in medical accelerator.
    Sohrabi M; Malekitakbolagh M; Nedaei HA
    Sci Rep; 2024 Apr; 14(1):9557. PubMed ID: 38664481
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study.
    Jahnen M; Amiel T; Kirchoff F; Büchler JW; Herkommer K; Rothe K; Meissner VH; Gschwend JE; Lunger L
    World J Urol; 2024 Apr; 42(1):260. PubMed ID: 38664275
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genomic Correlates of prostate-Specific Membrane Antigen Expression and Response to
    Raychaudhuri R; Mo G; Tuchayi AM; Graham L; Gulati R; Pritchard CC; Haffner MC; Yezefski T; Hawley JE; Cheng HH; Yu EY; Grivas P; Montgomery RB; Nelson PS; Chen DL; Hope T; Iravani A; Schweizer MT
    JCO Precis Oncol; 2024 Apr; 8():e2300634. PubMed ID: 38662984
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
    Lee LJ; Han CJ; Saligan L; Wallen GR
    Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. AZGP1 deficiency promotes angiogenesis in prostate cancer.
    Wen RM; Qiu Z; Marti GEW; Peterson EE; Marques FJG; Bermudez A; Wei Y; Nolley R; Lam N; Polasko AL; Chiu CL; Zhang D; Cho S; Karageorgos GM; McDonough E; Chadwick C; Ginty F; Jung KJ; Machiraju R; Mallick P; Crowley L; Pollack JR; Zhao H; Pitteri SJ; Brooks JD
    J Transl Med; 2024 Apr; 22(1):383. PubMed ID: 38659028
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer.
    Ying Y; Wu Y; Zhang F; Tang Y; Yi J; Ma X; Li J; Chen D; Wang X; Liu X; Liu B; Luo J; Zheng X; Xie L
    Mol Cancer; 2024 Apr; 23(1):79. PubMed ID: 38658974
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Molecular subtypes provide possibilities for precision medicine in a advanced prostate cancer].
    Wikström P; Bergh A; Josefsson A; Thysell E; Welén K
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38656744
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Developing a Novel Enzalutamide-Resistant prostate cancer Model via AR F877L Mutation in LNCaP Cells.
    Wang R; Ma S; Xu N; Gan Y; Li P; Zhang J; Zhang Z; Gu Q; Xiang J
    Curr Protoc; 2024 Apr; 4(4):e1033. PubMed ID: 38652202
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Drastic changes in the treatment of metastatic prostate cancer].
    Thellenberg Karlsson C; Ståhl O
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38651316
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Antibacterial prophylaxis with fosfomycin at the time of the urethral catheter removal after radical prostatectomy (prospective randomized trial)].
    Veliev E I; Sokolov E A; Metelev A Y; Aliev E N; Polyakova A S; Ivkin E V
    Urologiia; 2024 Mar; (1):35-40. PubMed ID: 38650404
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [
    Arbuznikova D; Klotsotyra A; Uhlmann L; Domogalla LC; Steinacker N; Mix M; Niedermann G; Spohn SKB; Freitag MT; Grosu AL; Meyer PT; Gratzke C; Eder M; Zamboglou C; Eder AC
    Theranostics; 2024; 14(6):2560-2572. PubMed ID: 38646643
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [A Case of Adenocarcinoma of Pancreatic Head of Liver Disfunction after Pancreaticoduodenectomy with Celiac Artery Stenosis Treated by Urgent Median Arcuate Ligament Release].
    Matsushita K; Yokoyama S; Hashimoto K; Uchiyama Y; Mizuno T; Kawai K; Kobayashi T; Saso K; Komori T; Kishi K; Fukunaga M
    Gan To Kagaku Ryoho; 2024 Apr; 51(4):448-450. PubMed ID: 38644318
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Bioinformatics-based analysis of the effect of general Transcription Factor IIH on prognosis of prostate cancer].
    Li JC; Zhu XJ; Ye JH; Tan ZH; Cai SH; Deng YL; Chen J; Tian WC; Luo DH; Zhong WD
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1410-1417. PubMed ID: 38644292
    [No Abstract]    [Full Text] [Related]  

  • 20. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
    Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 3040.